Fumaric Acid

Fumaric Acid

SCHEMBL718708

C=COCC.O=C(O)C=CC(=O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 8/20 0.52
TSHR P16473 3/20 0.43
TP53 P04637 1/20 0.43
EGLN1 Q9GZT9 1/20 0.43
EGLN3 Q9H6Z9 1/20 0.43
LMNA P02545 1/20 0.35
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL5854822 1.00 HCAR2 (0.52) HCAR2TSHRTP53EGLN1EGLN3
Fumaric Acid SCHEMBL28225492 1.00 HCAR2 (0.52) HCAR2TSHRTP53EGLN1EGLN3
Fumaric Acid SCHEMBL11785692 0.88 HCAR2 (0.42) HCAR2TSHRTP53EGLN1EGLN3
Monomethyl Fumarate SCHEMBL11322975 0.88 HCAR2 (0.63) HCAR2TSHRTP53EGLN1EGLN3
Monomethyl Fumarate SCHEMBL11322974 0.88 HCAR2 (0.63) HCAR2TSHRTP53EGLN1EGLN3
Fumaric Acid SCHEMBL11782248 0.88 HCAR2 (0.42) HCAR2TSHRTP53EGLN1EGLN3
Acrylic Acid SCHEMBL28659504 0.88 LMNA (0.50) HCAR2TSHRTP53LMNAALDH1A1
Bicarbonate SCHEMBL28785631 0.87
Acetic Acid SCHEMBL6676468 0.85
Acrylic Acid SCHEMBL29073994 0.84 LMNA (0.46) HCAR2TSHRLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6896903-B2 Bioadhesive compositions FIRST WATER LIMITED (GB) 2005-05-24 US claimed
EP-1163309-B1 BIOADHESIVE COMPOSITIONS FIRST WATER LTD (GB) 2004-06-09 EP claimed
US-20020026005-A1 Bioadhesive compositions FIRST WATER LIMITED (GB) 2002-02-28 US claimed
US-20020015689-A1 Bioadhesive compositions FIRST WATER LIMITED (GB) 2002-02-07 US claimed
EP-1163309-A1 BIOADHESIVE COMPOSITIONS First Water Limited (GB) 2001-12-19 EP claimed
EP-1150721-A1 BIOADHESIVE COMPOSITIONS First Water Limited (GB) 2001-11-07 EP claimed
WO-2000046319-A1 BIOADHESIVE COMPOSITIONS FIRST WATER LIMITED (GB) 2000-08-10 WO claimed
WO-2000045864-A1 BIOADHESIVE COMPOSITIONS FIRST WATER LIMITED (GB) 2000-08-10 WO claimed
EP-1026219-A1 Bioadhesive compositions First Water Limited (GB) 2000-08-09 EP claimed
US-11369553-B2 Therapeutic oral composition COLGATE-PALMOLIVE COMPANY (US) 2022-06-28 US disclosed
US-20170128340-A1 THERAPEUTIC ORAL COMPOSITION COLGATE-PALMOLIVE COMPANY (US) 2017-05-11 US disclosed
US-20120052025-A1 BORINIC COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2012-03-01 US disclosed
US-7152601-B2 Strapless respiratory face mask Barakat, Mohamed Ali (IT) 2006-12-26 US disclosed
EP-1313414-B1 ANTI-SNORING DEVICE COMPRISING A SKIN COMPATIBLE ADHESIVE BARAKAT MOHAMED ALI (BE) 2006-08-23 EP disclosed
EP-1026219-A1 Bioadhesive compositions First Water Limited (GB) 2000-08-09 EP disclosed
EP-1025867-A1 Disposable human waste management devices with improved adhesive flange to facilitate adhesion in oily conditions THE PROCTER & GAMBLE COMPANY (US) 2000-08-09 EP disclosed
EP-1025824-A1 Disposable human waste management devices with improved adhesive flange THE PROCTER & GAMBLE COMPANY (US) 2000-08-09 EP disclosed
EP-1014921-A1 ENZYMATIC FOAM COMPOSITIONS FOR DYEING KERATINOUS FIBRES NOVO NORDISK A/S (DK) 2000-07-05 EP disclosed
WO-1999015137-A1 ENZYMATIC FOAM COMPOSITIONS FOR DYEING KERATINOUS FIBRES NOVO NORDISK A/S (DK) 1999-04-01 WO disclosed
EP-0177765-B1 SILVER HALIDE COLOR PHOTOGRAPHIC MATERIAL FUJI PHOTO FILM CO., LTD. (JP) 1990-03-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020015689-A1 Bioadhesive compositions EPCAM, PHOSPHO1, DSG1 HCAR2 3185/4885TSHR 4376/4885TP53 2003/4885
US-20120052025-A1 BORINIC COMPOSITIONS CCL11, BDKRB2, BTD HCAR2 676/4885TSHR 4588/4885TP53 3849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.